Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Intercure Ltd

InterCure Ltd. INCR INCR INCR, doing business as Canndoc, announced record preliminary financial results for the fourth quarter of 2021.

InterCure Reports Record Preliminary 2021 Fourth Quarter Revenue - 3 Times YoY and 24% QoQ Growth.

Canopy Growth reports Q3-2022 premarket on Wednesday (02/09).

Canopy Growth: Insight Into Upcoming Q3-2022 Earnings

This Canadian pot company was the first to impress customers with cannabis derivatives, so what went wrong?

2 Years Later, Cannabis 2.0 Isn't Saving Canopy Growth

Cameco

CVS Health

Merger Monday was living up to its name, as Frontier Airlines has announced a merger with Spirit Airlines aimed at creating the lowest-cost U.S.

Earnings Previews: Cameco, Canopy Growth, CVS Health

Massive rights agreements should set the tone going forward but not everyone is convinced just yet

1 Red Flag for Canopy Growth in 2022, and 1 Green Flag

Tilray Brands

Marijuana stocks in Canada continue to tumble as fierce competition prevents the big brands on U.S exchanges from capturing a larger share of the Canadian market. So, which Canadian marijuana stocks should investors keep a close eye on?

2 Canadian marijuana stocks to keep a close eye on

Evogene

HEXO Corp

Neptune Wellness Solutions Inc.

PepsiCo

Dr. Reddy's Labs

22nd Century Group

Welcome back to our weekly series,  Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks, and look at how the cannabis industry is shaping up as we kick off 2022.

These Pot Stocks Went Wild This Week

Canadian Marijuana Stocks For Your 2022 Watchlist The post 2 Canadian Marijuana Stocks To Watch Right Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

2 Canadian Marijuana Stocks To Watch Right Now

OrganiGram Holdings Inc.

It has been more than three years since Canada legalized marijuana, but many producers in the country continue to struggle.

4 Eye-Popping Charts Depicting the State of the Canadian Pot Market

Aurora Cannabis

Cronos Group

Columbia Care Inc. and Trulieve Cannabis Corp. announced separate debt deals in recent days as cannabis companies turn away from issuing stock to raise capital in the face of weak share prices.

Cannabis Watch: Cannabis companies pivot to debt to raise capital as stock prices lag

New product launches across the CBD product portfolio and robust demand for legal cannabis products are likely to drive Canopy Growth's (CGC) Q3 top line.

What's in Store for Canopy Growth (CGC) in Q3 Earnings?

Canopy Growth Corporation WEED CGC announced the extension of the Ace Valley brand portfolio, bringing two new beverages and hard candy formats to market. Marking the brand's first-ever beverage offerings, Daylight and Moonwave are occasion-based ready-to-drink THC and CBD-infused drinks designed to help consumers start and end their days.

Canopy Growth's Ace Valley Brand Launches New Cannabis Beverages & CBD Hard Candies

Marijuana banking legislation advances in the House. But will it make a difference?

Why Marijuana Stocks Hit a Pot-Hole Today

BioSteel Sports Nutrition Inc., which is part-owned by Canopy Growth Corporation CGC announced a series of new deals with retailers that bring the brand's lineup of Clean. Healthy. Hydration.

Canopy Growth's BioSteel Sells Sports Drinks To Nearly 15,000 Stores Across U.S.

Constellation Brands

The marijuana investment is hurting the core alcohol business.

How The Canopy Growth Acquisition Is Weighing on Constellation Brands

SNDL Inc.

Are You Watching These Pot Stocks? The post Top Canadian Marijuana Stocks To Watch In February 2022 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top Canadian Marijuana Stocks To Watch In February 2022

Cannabis industry expert Alan Brochstein on 2022 catalysts.

Alan Brochstein On Cannabis Investing In 2022 (Video Transcript)

Akerna Corp

The Valens Co

One Extremely Hot Week in Cannabis Stocks Wraps up January

Since the beginning of the year, Canopy Growth CGC shares dropped 28.05% to $6.85 per share. In December, the Ontario-based cannabis giant divested its CBD subsidiary assets in Germany as part of its rationalization strategy.

Will Constellation Brands Use Canopy Growth Stock Drop To Acquire Higher Stake? Analyst Thoughts

SMITHS FALLS, ON , Jan. 26, 2022 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) will release its financial results for the third quarter fiscal year 2022 ended December 31, 2021 before financial markets open on February 9, 2022. Following the release of its third quarter fiscal year 2022 financial results, Canopy Growth will host an audio webcast with David Klein, CEO and Judy Hong, Interim CFO at 10:00 AM Eastern Time on February 9, 2022.

Canopy Growth to Report Third Quarter Fiscal 2022 Financial Results on February 9, 2022

IM Cannabis Corp

Top Pot Stocks For Your List Before February The post Top Marijuana Stocks To Add To You Watchlist Before February appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top Marijuana Stocks To Add To You Watchlist Before February

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

Altria

Trulieve Cannabis Corp.

While the U.S. pot growers had an amazing 2021, dark clouds loomed over their Canadian counterparts.

Canadian Pot Stocks Had a Disappointing Year. Will 2022 Be Better?

The legal cannabis industry in Canada must continue to consolidate to make it an attractive space for investors.

This Megamerger Might Be Required Before Canadian Cannabis Stocks Can Rebound

Select analysts and investment banks see "high" return potential for these cannabis stocks.

3 Ultra-Popular Pot Stocks With 46% to 152% Upside, According to Wall Street

Village Farms International

2 Marijuana Stocks To Watch In 2022 That Could Be Worth Buying The post Looking For Marijuana Stocks To Buy In 2022? These 2 May Be Worth it appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Looking For Marijuana Stocks To Buy In 2022? These 2 May Be Worth it

News for Canopy Growth Stock (CGC)